Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma

NCT07126990 is registered in ClinicalTrials.gov with Xiaorong Wu as lead sponsor.

NCT NCT07126990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07126990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma
Lead sponsor
Xiaorong Wu
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
February 12, 2025
Completion date
August 30, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma